In conclusion, we provide direct evidence that the knockdown of CA125/MUC16 in NIH:OVCAR3 ovarian cancer cells alters epithelial and mesenchymal markers, cell motility and migration. This evidence concerns the gene MUC16 and ovarian carcinoma.